£V3PB
Dit fonds streeft ernaar de FTSE Developed Asia Pacific All Cap Choice Index te volgen, die large-, mid- en smallcapaandelen omvat die op ESG-criteria zijn gescreend uit ontwikkelde markten in Azië en de Stille Oceaan, waaronder Japan.
Naam | Gewicht | Marktkapitalisatie | Prijs | Dagwijziging |
|---|---|---|---|---|
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,06% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,05% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
Greatland Resources £GGPMaterialen | 0,04% | - | ||
0,04% | N/A | N/A | N/A | |
0,04% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
Telix Pharmaceutical $TLXGezondheid | 0,03% | - | ||
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A | |
0,03% | N/A | N/A | N/A |